NEW YORK, March 17, 2017 /PRNewswire/ --
FinancialBuzz.com News Commentary
In a recent report byArcview Market Research, the legal cannabis market is arguably the fastest growing industry in the world. The data reported shows, that regulated cannabis sales in North America totaled $6.9 billion
As a result of the industry's growth, experts now expect a shift from sales on the black market, to gain steam in the legal cannabis market. "It's one of the major reasons that people are going to leave the underground market to go to the aboveground market. It's about variety," Arcview CEO Troy Dayton told Business Insider. "You just can't get these products on the underground market."
ChineseInvestors.com, Inc. (OTCQB: CIIX) on February 1st announced, the launch of its new website for its new subsidiary ChineseCBDoil.com. The website went live on January 31st, under the URL: http://www.ChineseCBDoil.com.
The Company is expanding into the medical marijuana industry with the launch of its website, and plans to retail hemp oil and related products, which are legal to sell and distribute within China, and in the United States, in all fifty states (hemp oil is not marijuana, but indeed a separate and distinct plant made from hemp). CBD oil, derived from hemp is a product with medicinal qualities that are primarily used for anti-inflammatory and other common ailments.
Mr. Warren Wang, the Chairman of ChineseInvestors.com stated: "I am very pleased to see the investor reaction to our announced plans which we began to disclose over a month ago. Indeed the market has responded with very strong interest in our shares, and as a result, we have achieved record trading volume and reached a new fifty-two week high in our shares last week."
Plant biotechnology company, 22nd Century Group Inc. (NYSE: XXII), is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants, through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties, development of X-22, a smoking cessation aid consisting of very low nicotine cigarettes, manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes, production of SPECTRUM research cigarettes for the National Institute on Drug Abuse; contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol, plants with high levels of cannabidiol, and other non-THC cannabinoids.
Development-stage company that operates in the cannabis and industrial hemp space in America, Medical Marijuana Inc. (OTCQB: MJNA), announced that its subsidiary HempMeds® Mexico, had held a press conference in Mexico, to reveal the positive results of a recent study conducted by renowned Mexican physician, Dr. Saul Garza Morales, on the effects of the Company's Real Scientific Hemp Oil-X™ (RSHO-X™) product in treating children with severe epilepsy. The study, conducted by Mexican pediatric neurologist Dr. Garza, included 39 patients with Lennox-Gastaut syndrome, a severe form of pediatric epilepsy that typically develops before the age of four. Of those 39 patients, which took up to 5-7mg CBD/kg progressive doses of RSHO-X™ 5000MG, 84% experienced reduction in motor seizures; 53% reported better than a 75% reduction in seizures; and 7 reported a complete elimination of all seizures, over a 4-month period, with zero reported side effects.
OWC Pharmaceuticals (OTCQB: OWCP) is focused on the development of two delivery systems: A proprietary, cannabinoid-enriched sublingual tablet and a proprietary topical compound. The company developed its cannabinoid-enriched sublingual tablet for the administration of medical cannabis, near the end of last year. The tablet was developed to increase the bioavailability of cannabinoids and provide an optimal administration method for consistent dosing. The company plans to develop the tablet to treat conditions like multiple myeloma, post-traumatic stress disorder, and fibromyalgia. OWC Pharmaceuticals formulated a topical cannabinoid-based cream for the treatment of psoriasis, in partnership with Emilia Cosmetics Ltd., one of Israel's largest cosmetic manufacturers.
Through Terra Tech Corporation (OTCQX: TRTC) together with its subsidiaries, engages in the design, marketing, and sale of hydroponic equipment with proprietary technology, to create sustainable solutions for the cultivation of indoor agriculture in Newport Beach and Irvine, California. It operates through two segments: Hydroponic Produce and Cannabis Products. It also operates as a retail seller of hydroponic produce, herbs, and floral products, which are distributed in the Midwest and the Northeast United States; and produces and sells a line of cannabis flowers and cigarettes, as well as a line of cannabis pure concentrates, including oils, waxes, shatters, and clears to dispensaries in California.
Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information: Media Contact: E-mail: firstname.lastname@example.org Phone: +1-877-601-1879
Subscribe to our Free Newsletters!
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...
Unintended pregnancies are very common these days, and so one in about four pregnant women go for ...View All